Biotype as determinant of natural immunising effect of cholera

J. D. Clemens, F. van Loon, D. A. Sack, M. R. Rao, F. Ahmed, J. Chakraborty, B. A. Kay, M. R. Khan, M. Yunus, J. R. Harris, J. D. Clemens, M. R. Rao, D. A. Sack, J. R. Harris, J. D. Clemens, M. R. Rao, A. M. Svennerholm, J. Holmgren

Research output: Contribution to journalArticle

Abstract

To test the hypothesis that clinical Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61% lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection.

Original languageEnglish (US)
Pages (from-to)883-884
Number of pages2
JournalThe Lancet
Volume337
Issue number8746
DOIs
StatePublished - Apr 13 1991
Externally publishedYes

Fingerprint

Cholera
Vibrio cholerae
Bangladesh
Rural Population
Incidence
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clemens, J. D., van Loon, F., Sack, D. A., Rao, M. R., Ahmed, F., Chakraborty, J., ... Holmgren, J. (1991). Biotype as determinant of natural immunising effect of cholera. The Lancet, 337(8746), 883-884. https://doi.org/10.1016/0140-6736(91)90207-6

Biotype as determinant of natural immunising effect of cholera. / Clemens, J. D.; van Loon, F.; Sack, D. A.; Rao, M. R.; Ahmed, F.; Chakraborty, J.; Kay, B. A.; Khan, M. R.; Yunus, M.; Harris, J. R.; Clemens, J. D.; Rao, M. R.; Sack, D. A.; Harris, J. R.; Clemens, J. D.; Rao, M. R.; Svennerholm, A. M.; Holmgren, J.

In: The Lancet, Vol. 337, No. 8746, 13.04.1991, p. 883-884.

Research output: Contribution to journalArticle

Clemens, JD, van Loon, F, Sack, DA, Rao, MR, Ahmed, F, Chakraborty, J, Kay, BA, Khan, MR, Yunus, M, Harris, JR, Clemens, JD, Rao, MR, Sack, DA, Harris, JR, Clemens, JD, Rao, MR, Svennerholm, AM & Holmgren, J 1991, 'Biotype as determinant of natural immunising effect of cholera', The Lancet, vol. 337, no. 8746, pp. 883-884. https://doi.org/10.1016/0140-6736(91)90207-6
Clemens JD, van Loon F, Sack DA, Rao MR, Ahmed F, Chakraborty J et al. Biotype as determinant of natural immunising effect of cholera. The Lancet. 1991 Apr 13;337(8746):883-884. https://doi.org/10.1016/0140-6736(91)90207-6
Clemens, J. D. ; van Loon, F. ; Sack, D. A. ; Rao, M. R. ; Ahmed, F. ; Chakraborty, J. ; Kay, B. A. ; Khan, M. R. ; Yunus, M. ; Harris, J. R. ; Clemens, J. D. ; Rao, M. R. ; Sack, D. A. ; Harris, J. R. ; Clemens, J. D. ; Rao, M. R. ; Svennerholm, A. M. ; Holmgren, J. / Biotype as determinant of natural immunising effect of cholera. In: The Lancet. 1991 ; Vol. 337, No. 8746. pp. 883-884.
@article{e58d9901977e4a7397dcccbbd5f05e2a,
title = "Biotype as determinant of natural immunising effect of cholera",
abstract = "To test the hypothesis that clinical Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61{\%} lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection.",
author = "Clemens, {J. D.} and {van Loon}, F. and Sack, {D. A.} and Rao, {M. R.} and F. Ahmed and J. Chakraborty and Kay, {B. A.} and Khan, {M. R.} and M. Yunus and Harris, {J. R.} and Clemens, {J. D.} and Rao, {M. R.} and Sack, {D. A.} and Harris, {J. R.} and Clemens, {J. D.} and Rao, {M. R.} and Svennerholm, {A. M.} and J. Holmgren",
year = "1991",
month = "4",
day = "13",
doi = "10.1016/0140-6736(91)90207-6",
language = "English (US)",
volume = "337",
pages = "883--884",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8746",

}

TY - JOUR

T1 - Biotype as determinant of natural immunising effect of cholera

AU - Clemens, J. D.

AU - van Loon, F.

AU - Sack, D. A.

AU - Rao, M. R.

AU - Ahmed, F.

AU - Chakraborty, J.

AU - Kay, B. A.

AU - Khan, M. R.

AU - Yunus, M.

AU - Harris, J. R.

AU - Clemens, J. D.

AU - Rao, M. R.

AU - Sack, D. A.

AU - Harris, J. R.

AU - Clemens, J. D.

AU - Rao, M. R.

AU - Svennerholm, A. M.

AU - Holmgren, J.

PY - 1991/4/13

Y1 - 1991/4/13

N2 - To test the hypothesis that clinical Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61% lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection.

AB - To test the hypothesis that clinical Vibrio cholerae 01 infections protect against recurrent cholera, treated cholera episodes in a rural Bangladesh population of 188 153 people who were followed between 1985 and 1988 were analysed. Of the 2214 people with initial episodes of cholera, 7 had a second episode. The incidence of cholera was 61% lower in subjects who had had an earlier episode than in those without such an episode. Whereas initial episodes of classical cholera were associated with complete protection against subsequent cholera, initial episodes of El Tor cholera were associated with negligible protection.

UR - http://www.scopus.com/inward/record.url?scp=0025891728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025891728&partnerID=8YFLogxK

U2 - 10.1016/0140-6736(91)90207-6

DO - 10.1016/0140-6736(91)90207-6

M3 - Article

C2 - 1672971

AN - SCOPUS:0025891728

VL - 337

SP - 883

EP - 884

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8746

ER -